TY  - JOUR
AU  - Pulte, Dianne
AU  - Weberpals, Janick
AU  - Schröder, Chloé Charlotte
AU  - Emrich, Katharina
AU  - Holleczek, Bernd
AU  - Katalinic, Alexander
AU  - Luttmann, Sabine
AU  - Sirri, Eunice
AU  - Jansen, Lina
AU  - Brenner, Hermann
TI  - Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.
JO  - International journal of cancer
VL  - 143
IS  - 2
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2018-00703
SP  - 324 - 332
PY  - 2018
AB  - Hepatobiliary tract cancers (HBTCs) are a heterogeneous group of cancers with high mortality. Because most of these cancers, with the exception of hepatocellular carcinoma (HCC), are rare, few data are available concerning the population level survival expectations of patients with HBTC. Here, we describe survival of patients with HBTC in Germany with comparison to survival in the US. Therefore, data were extracted from 12 databases in Germany and the Surveillance, Epidemiology and End Results (SEER13) database in the US. Period analysis and modeled period analysis were used to calculate 5-year relative survival estimates for patients with HBTC diagnosed from 1997 to 2013. HCC was the most common HBTC in each database, accounting for over 1/3 of HBTC in Germany and about half of cases in the US. Overall age adjusted 5-year relative survival for HBTC in 2006-2013 was 19.1
LB  - PUB:(DE-HGF)16
C6  - pmid:29479701
DO  - DOI:10.1002/ijc.31322
UR  - https://inrepo02.dkfz.de/record/135966
ER  -